Long-term follow-up for sleep apnea study
Part of Brain & nervous system, Lungs & breathing clinical trials.
This is a follow-up study for people with obstructive sleep apnea who have already completed two prior studies with the same medicine. The goal is to keep tracking your health and the medicine's effects over a longer time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You already took part in and finished two earlier studies (APC-APN-304 and APC-APN-305) without stopping the study medicine early.
- You need to be in generally good health and not have any new medical problems that would make this study unsafe for you.
- Your doctor must agree that it's safe for you to continue based on your current health and any other treatments you're taking.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how CPAP (a breathing machine) or a custom mouth guard (MAD) affects sleep over the long term in people with obstructive sleep apnea. It may help confirm which treatment improves sleep and how well it works over time.
This study tests a medicine called acetazolamide to see if it can improve how your brain controls breathing during sleep apnea. If you have sleep apnea and are not using treatment, you might be able to join.
This study evaluates a new APAP (automatic positive airway pressure) device called Elara for treating obstructive sleep apnea. You'll use the device and have sleep monitoring to see how well it works for you.
This study compares three treatments for obstructive sleep apnea: a CPAP machine, a dental mouthpiece, and a combination of two medications (atomoxetine and oxybutynin). Researchers want to see which works best for people recently diagnosed with sleep apnea.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This study tests whether atomoxetine and DAW2022 can improve how severe obstructive sleep apnea is. It may help by changing breathing patterns during sleep, measured through physiology tests.
Hear when a new OSA trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.